47.73.Z - Retail sale of pharmaceutical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade
47 - Retail trade
55 - Accommodation
68 - Real estate activities
70 - Head office activities and management consultancy
86 - Healthcare
87 - Social assistance with accommodation
88 - Social assistance without accommodation
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,5 | 0,4 | 0,7 | 77 |
EBITDA | 0,6 | 0,5 | 0,8 | 68,2 |
Short time liabilities | 2,3 | 2,8 | 2,2 | -20,8 |
Equity capital | 1,5 | 1,4 | 1,7 | 23,9 |
Operating profit (EBIT) | 0,5 | 0,4 | 0,8 | 81,7 |
Assets | 3,8 | 4,2 | 3,9 | -6,2 |
Net profit (loss) | 0,5 | 0,4 | 0,7 | 77 |
Cash | 0,6 | 1 | 0,7 | -24,2 |
Liabilities and provisions for liabilities | 2,4 | 2,8 | 2,3 | -20,5 |
Net income from sale | 9,8 | 10,5 | 11,1 | 5,8 |
Working assets | 1,5 | 1,8 | 1,8 | -2,1 |
Depreciation | 0 | 0 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | 36,1 | 31 | 44,3 | 13,3 |
Equity capital to total assets | 38,4 | 32,4 | 42,7 | 10,3 |
Gross profit margin | 5,4 | 4 | 6,7 | 2,7 |
EBITDA Margin | 5,9 | 4,4 | 6,9 | 2,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 86 | 98 | 73 | -25 |
Current financial liquidity indicator | 0.6333321928977966 | 0.6402803659439087 | 0.7900394201278687 | 0,2 |
Net dept to EBITDA | 0.07201183587312698 | -1.2695164680480957 | -0.926548957824707 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane